Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian Higgins
Phase 1 Study of the MDM2 Antagonist RO6839921 in Patients With Acute Myeloid Leukemia
Investigational New Drugs
Oncology
Pharmacology
Dysregulated Expression of Androgen-Responsive and Nonresponsive Genes in the Androgen-Independent Prostate Cancer Xenograft Model, CWR22-R
Nature Genetics
Genetics
Related publications
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A New Peptide Vaccine OCV-501: In Vitro Pharmacology and Phase 1 Study in Patients With Acute Myeloid Leukemia
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
AML1 (Acute Myeloid Leukemia 1)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Superior Anti-Tumor Activity of the MDM2 Antagonist Idasanutlin and the BCL-2 Inhibitor Venetoclax in P53 Wild-Type Acute Myeloid Leukemia Models
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Challenges in Treating Older Patients With Acute Myeloid Leukemia
Journal of Oncology
Oncology
The mTOR Inhibitor Everolimus in Combination With Azacitidine in Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase Ib/Ii Study
Oncotarget
Oncology
A Randomised Phase II Study of Interleukin-1 Receptor Antagonist in Acute Stroke Patients
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
How I Treat Older Patients With Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology